Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04146766
Other study ID # 2-108-05-132
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 18, 2019
Est. completion date October 5, 2020

Study information

Verified date March 2021
Source National Defense Medical Center, Taiwan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This article uses the smart medical case management tracking system, combined with various terminal devices to fully record the measured data (pulse, blood pressure) for case home care tracking to prevent the occurrence and deterioration of the disease. Therefore, with the promotion of the eHealth medical staff and members of the family can instantly grasp the health of the body and cultivate the habits of self-health management and enhance the quality of care. Therefore, we hope to use the Smart Health Cloud as an interventional measure to improve the care of patients with coronary artery disease, improve self-management ability and quality of life.


Description:

The World Health Organization points out that cardiovascular disease is the number one killer of global deaths, killing 17.1 million people worldwide each year, accounting for 31% of the world's total deaths. Heart disease is the second leading cause of death in China. Coronary artery disease (CAD) is the majority, and coronary artery disease is the most common cardiovascular disease. Good self-management can reduce disease risk factors and improve related prognosis. It is also an important issue in health promotion around the world. This article uses the smart medical case management tracking system, combined with various terminal devices to fully record the measured data (pulse, blood pressure) for case home care tracking to prevent the occurrence and deterioration of the disease. Therefore, with the promotion of the eHealth medical staff and members of the family can instantly grasp the health of the body and cultivate the habits of self-health management and enhance the quality of care. Therefore, we hope to use the Smart Health Cloud as an interventional measure to improve the care of patients with coronary artery disease, improve self-management ability and quality of life.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date October 5, 2020
Est. primary completion date July 15, 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - A patient who is 20 years of age or older and has a Coronary computed tomography angiography >50% vascular stenosis, has been PTCA?stent or CABG - Taiwanese, understand Chinese Exclusion Criteria: - Those who can't express their wishes clearly (such as Azheimer's disease, mental dysfunction) - mental disorder - infectious diseases - Patients who participate in other research projects

Study Design


Intervention

Combination Product:
eHealth
The study was randomized (wait-list-control), and it was estimated that 60 subjects were randomly assigned to the immediate treatment group and the wait-list-control group. The two groups were tested for baseline before intervention in the eHealth. After the first questionnaire evaluation, the experimental group was involved in the eHealth for three months, and after three months, the experimental group and the waiting intervention control group were post-tested. To assess the effectiveness of the two groups before and after the eHealth . Control group that waits for intervention in the fourth month from the beginning of the fourth month to the end of the sixth month

Locations

Country Name City State
Taiwan TSGH Taipei city

Sponsors (1)

Lead Sponsor Collaborator
National Defense Medical Center, Taiwan

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Other Quality of life scale-T1 use WHOQOL-BREF Taiwan Version. total of 28 questions,The scoring method uses the five-point Likert Scales score The questionnaire has a total of 28 questions, with at least one point for each question and a maximum of five points. The higher the score, the better the quality of life. T1-baseline
Other Quality of life scale-T2 use WHOQOL-BREF Taiwan Version. total of 28 questions,The scoring method uses the five-point Likert Scales score The questionnaire has a total of 28 questions, with at least one point for each question and a maximum of five points. The higher the score, the better the quality of life. T2-three months later
Other Quality of life scale-T3 use WHOQOL-BREF Taiwan Version. total of 28 questions,The scoring method uses the five-point Likert Scales score The questionnaire has a total of 28 questions, with at least one point for each question and a maximum of five points. The higher the score, the better the quality of life. T3-six months later
Other Modified Health care machine rating scale There are three questions in the satisfaction survey. Use category options to measure usage satisfaction T2-three months later
Primary physiological indicators-HDL-C(T1) HDL-C, the unit is mg/dL T1-baseline
Primary physiological indicators-HDL-C(T2) HDL-C, the unit is mg/dL T2-three months later
Primary physiological indicators-HDL-C(T3) HDL-C, the unit is mg/dL T3-six months later
Primary physiological indicators-LDL-C(T1) LDL-C, the unit is mg/dL T1-baseline
Primary physiological indicators-LDL-C(T2) LDL-C, the unit is mg/dL T2-three months later
Primary physiological indicators-LDL-C(T3) LDL-C, the unit is mg/dL T3-six months later
Primary physiological indicators-Total Cholesterol(T1) Total Cholesterol, the unit is mg/dL T1-baseline
Primary physiological indicators-Total Cholesterol(T2) Total Cholesterol, the unit is mg/dL T2-three months later
Primary physiological indicators-Total Cholesterol(T3) Total Cholesterol, the unit is mg/dL T3-six months later
Primary physiological indicators-Triglyceride(T1) Triglyceride, the unit is mg/dL T1-baseline
Primary physiological indicators-Triglyceride(T2) Triglyceride, the unit is mg/dL T2-three months later
Primary physiological indicators-Triglyceride(T3) Triglyceride, the unit is mg/dL T3-six months later
Primary physiological indicators-GLU(T1) GLU, the unit is mg/dL T1-baseline
Primary physiological indicators-GLU(T2) GLU, the unit is mg/dL T2-three months later
Primary physiological indicators-GLU(T3) GLU, the unit is mg/dL T3-six months later
Primary physiological indicators-HbA1C(T1) HbA1C, the unit is % T1-baseline
Primary physiological indicators-HbA1C(T2) HbA1C, the unit is % T2-three months later
Primary physiological indicators-HbA1C(T3) HbA1C, the unit is % T3-six months later
Secondary self-management-T1 use The partners in Health scale. total of 12 questions,The scoring method uses the nine-point Likert Scales score. The score of 0 is divided into self-management performance, and the score of 8 indicates that self-management is good. The total score is 96 points. The higher the score, the better the self-management. T1-baseline
Secondary self-management-T2 use The partners in Health scale. total of 12 questions,The scoring method uses the nine-point Likert Scales score. The score of 0 is divided into self-management performance, and the score of 8 indicates that self-management is good. The total score is 96 points. The higher the score, the better the self-management. T2-three months later
Secondary self-management-T3 use The partners in Health scale. total of 12 questions,The scoring method uses the nine-point Likert Scales score. The score of 0 is divided into self-management performance, and the score of 8 indicates that self-management is good. The total score is 96 points. The higher the score, the better the self-management. T3-six months later
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A